- Home
- PEGY vs CVKD Comparison
PEGY vs CVKD Comparison
Compare PEGY & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEGY
- CVKD
- Stock Information
- Founded
- PEGY 1969
- CVKD 2022
- Country
- PEGY United States
- CVKD United States
- Employees
- PEGY N/A
- CVKD N/A
- Industry
- PEGY Metal Fabrications
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- PEGY Industrials
- CVKD Health Care
- Exchange
- PEGY Nasdaq
- CVKD Nasdaq
- Market Cap
- PEGY 1.0M
- CVKD 17.1M
- IPO Year
- PEGY N/A
- CVKD 2023
- Fundamental
- Price
- PEGY $5.09
- CVKD $14.45
- Analyst Decision
- PEGY
- CVKD Strong Buy
- Analyst Count
- PEGY 0
- CVKD 2
- Target Price
- PEGY N/A
- CVKD $52.50
- AVG Volume (30 Days)
- PEGY 2.3M
- CVKD 59.6K
- Earning Date
- PEGY 11-07-2024
- CVKD 11-08-2024
- Dividend Yield
- PEGY N/A
- CVKD N/A
- EPS Growth
- PEGY N/A
- CVKD N/A
- EPS
- PEGY N/A
- CVKD N/A
- Revenue
- PEGY $64,499,610.00
- CVKD N/A
- Revenue This Year
- PEGY $12.33
- CVKD N/A
- Revenue Next Year
- PEGY N/A
- CVKD N/A
- P/E Ratio
- PEGY N/A
- CVKD N/A
- Revenue Growth
- PEGY N/A
- CVKD N/A
- 52 Week Low
- PEGY $4.68
- CVKD $5.40
- 52 Week High
- PEGY $735.00
- CVKD $32.55
- Technical
- Relative Strength Index (RSI)
- PEGY 33.11
- CVKD 56.80
- Support Level
- PEGY $4.68
- CVKD $11.19
- Resistance Level
- PEGY $12.18
- CVKD $17.95
- Average True Range (ATR)
- PEGY 1.28
- CVKD 1.37
- MACD
- PEGY 1.33
- CVKD 0.10
- Stochastic Oscillator
- PEGY 7.60
- CVKD 49.64
About PEGY Pineapple Energy Inc.
Pineapple Energy Inc provides households with sustainable solar energy, back-up power and security, control and predictability, and cost savings. The company provides a full range of installation services, including the design, engineering, procurement, permitting, construction, grid connection, warranty, monitoring and maintenance of residential solar energy systems. It also offers battery storage to customers in select markets and serves a limited number of enterprise customers.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.